University spinoffs have remarkably strengthened the linkage between universities and industry. The number of technology patents and spinoffs coming out of university research has a significant impact on regional economic and social development.
In this episode of o2h ChaiTime, Sunil Shah hosted a discussion around UK and USA university spinouts to help understand both the academic and entrepreneur considerations to maximize stakeholder value.
Vinit Nijhawan, a visionary entrepreneur building companies that have been acquired by Boeing, Motorola and Qualcomm.Now he is Managing Director of Mass Ventures and an MBA lecturer at Boston University.
Works for The Sussex Innovation Centre engaging closely with the Knowledge Exchange office at the University of Sussex in supporting academics to spinout companies across a range of technologies.
Head of life science investments at Cambridge University, she is currently active with high profile spinouts Pharmenable, Spirea, Carrick Therapeutics, STORM Therapeutics, Z-factor, PhoreMost, Qkine and PolyProX.
Sunil is the CEO and Co-Founder of o2h ventures which involves discovery services / collaborations, seeding drug discovery, academic in-licensing and biotechnology incubation.